Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A chocolate-covered pretzel product is being recalled in three states due to the presence of an undeclared milk allergen.

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...

Robert F. Kennedy Jr.'s views on vaccines and his nomination for HHS secretary were questioned again in a second Senate hearing.

The 19th spoke to medical experts about what Kennedy can and can’t do around vaccines if confirmed to lead the Department of ...